228 related articles for article (PubMed ID: 26211532)
1. Genomic evidence of reactive oxygen species elevation in papillary thyroid carcinoma with Hashimoto thyroiditis.
Yi JW; Park JY; Sung JY; Kwak SH; Yu J; Chang JH; Kim JH; Ha SY; Paik EK; Lee WS; Kim SJ; Lee KE; Kim JH
Endocr J; 2015; 62(10):857-77. PubMed ID: 26211532
[TBL] [Abstract][Full Text] [Related]
2. Genetic relationship between Hashimoto`s thyroiditis and papillary thyroid carcinoma with coexisting Hashimoto`s thyroiditis.
Subhi O; Schulten HJ; Bagatian N; Al-Dayini R; Karim S; Bakhashab S; Alotibi R; Al-Ahmadi A; Ata M; Elaimi A; Al-Muhayawi S; Mansouri M; Al-Ghamdi K; Hamour OA; Jamal A; Al-Maghrabi J; Al-Qahtani MH
PLoS One; 2020; 15(6):e0234566. PubMed ID: 32603365
[TBL] [Abstract][Full Text] [Related]
3. [Differential protein expressions in papillary thyroid carcinoma patients with or without Hashimoto's thyroiditis].
Lu HZ; Zhang N; Liu W; Zhu XY; Qi D; Wang Y; Liu XY; Li ZJ
Zhonghua Zhong Liu Za Zhi; 2020 Jun; 42(6):463-468. PubMed ID: 32575941
[No Abstract] [Full Text] [Related]
4. Hashimoto's thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis.
Lun Y; Wu X; Xia Q; Han Y; Zhang X; Liu Z; Wang F; Duan Z; Xin S; Zhang J
Otolaryngol Head Neck Surg; 2013 Mar; 148(3):396-402. PubMed ID: 23300224
[TBL] [Abstract][Full Text] [Related]
5. Clinical relationship between Hashimoto's thyroiditis and papillary thyroid cancer.
Ahn D; Heo SJ; Park JH; Kim JH; Sohn JH; Park JY; Park SK; Park J
Acta Oncol; 2011 Nov; 50(8):1228-34. PubMed ID: 21871002
[TBL] [Abstract][Full Text] [Related]
6. Hashimoto's thyroiditis and papillary thyroid cancer: are they immunologically linked?
Ehlers M; Schott M
Trends Endocrinol Metab; 2014 Dec; 25(12):656-64. PubMed ID: 25306886
[TBL] [Abstract][Full Text] [Related]
7. Papillary Thyroid Carcinoma Emerging from Hashimoto Thyroiditis Demonstrates Increased PD-L1 Expression, Which Persists with Metastasis.
Lubin D; Baraban E; Lisby A; Jalali-Farahani S; Zhang P; Livolsi V
Endocr Pathol; 2018 Dec; 29(4):317-323. PubMed ID: 30121940
[TBL] [Abstract][Full Text] [Related]
8. IL-4, IL-10 and high sensitivity-CRP as potential serum biomarkers of persistent/recurrent disease in papillary thyroid carcinoma with/without Hashimoto's thyroiditis.
Stanciu AE; Serdarevic N; Hurduc AE; Stanciu MM
Scand J Clin Lab Invest; 2015 Nov; 75(7):539-48. PubMed ID: 26305420
[TBL] [Abstract][Full Text] [Related]
9. Expression of papillary thyroid carcinoma-associated molecular markers and their significance in follicular epithelial dysplasia with papillary thyroid carcinoma-like nuclear alterations in Hashimoto's thyroiditis.
Ma H; Yan J; Zhang C; Qin S; Qin L; Liu L; Wang X; Li N
Int J Clin Exp Pathol; 2014; 7(11):7999-8007. PubMed ID: 25550843
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of the Impact of Hashimoto Thyroiditis on Papillary Thyroid Carcinoma Progression: Relationship with the Tumor Immune Microenvironment.
Sulaieva O; Chernenko O; Selesnov O; Nechay O; Maievskyi O; Falalyeyeva T; Kobyliak N; Tsyryuk O; Penchuk Y; Shapochka D
Endocrinol Metab (Seoul); 2020 Jun; 35(2):443-455. PubMed ID: 32615729
[TBL] [Abstract][Full Text] [Related]
11. Hashimoto's thyroiditis and papillary thyroid carcinoma. Are cytokeratin 19 and P63 proteins of any diagnostic value?
Divani SN; Kalodimos GP; Lioupis MA; Syrmos NC
Hell J Nucl Med; 2016; 19(3):250-253. PubMed ID: 27824965
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics analysis identified shared differentially expressed genes as potential biomarkers for Hashimoto's thyroiditis-related papillary thyroid cancer.
Liu C; Pan Y; Li Q; Zhang Y
Int J Med Sci; 2021; 18(15):3478-3487. PubMed ID: 34522174
[No Abstract] [Full Text] [Related]
13. A comparative study of nuclear 8-hydroxyguanosine expression in Autoimmune Thyroid Diseases and Papillary Thyroid Carcinoma and its relationship with p53, Bcl-2 and Ki-67 cancer related proteins.
Mseddi M; Ben Mansour R; Gouiia N; Mnif F; Bousselaa R; Abid M; Boudaouara T; Attia H; Lassoued S
Adv Med Sci; 2017 Mar; 62(1):45-51. PubMed ID: 28187375
[TBL] [Abstract][Full Text] [Related]
14. Osteopontin levels in patients with papillary thyroid cancer according to the presence of Hashimoto's thyroiditis.
Park SH; Park CS; Kim YI; Nam-Goong IS; Kim YS; Lee JC; Choi JI; Park JW; Kim ES
Asian Pac J Cancer Prev; 2015; 16(6):2447-51. PubMed ID: 25824779
[TBL] [Abstract][Full Text] [Related]
15. Cytokine production in patients with papillary thyroid cancer and associated autoimmune Hashimoto thyroiditis.
Zivancevic-Simonovic S; Mihaljevic O; Majstorovic I; Popovic S; Markovic S; Milosevic-Djordjevic O; Jovanovic Z; Mijatovic-Teodorovic L; Mihajlovic D; Colic M
Cancer Immunol Immunother; 2015 Aug; 64(8):1011-9. PubMed ID: 25971541
[TBL] [Abstract][Full Text] [Related]
16. Clinical Relationship Between IgG4-Positive Hashimoto's Thyroiditis and Papillary Thyroid Carcinoma.
Yu Y; Zhang J; Lu G; Li T; Zhang Y; Yu N; Gao Y; Gao Y; Guo X
J Clin Endocrinol Metab; 2016 Apr; 101(4):1516-24. PubMed ID: 26866571
[TBL] [Abstract][Full Text] [Related]
17. RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma.
Rhoden KJ; Unger K; Salvatore G; Yilmaz Y; Vovk V; Chiappetta G; Qumsiyeh MB; Rothstein JL; Fusco A; Santoro M; Zitzelsberger H; Tallini G
J Clin Endocrinol Metab; 2006 Jun; 91(6):2414-23. PubMed ID: 16595592
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of lncRNA-mediated ceRNA regulatory networks and key genes associated with papillary thyroid cancer coexistent with Hashimoto's thyroiditis.
Zhang Y; Tian Y
BMC Endocr Disord; 2022 Oct; 22(1):252. PubMed ID: 36266640
[TBL] [Abstract][Full Text] [Related]
19. IL-17A increases MHC class I expression and promotes T cell activation in papillary thyroid cancer patients with coexistent Hashimoto's thyroiditis.
Han LT; Hu JQ; Ma B; Wen D; Zhang TT; Lu ZW; Wei WJ; Wang YL; Wang Y; Liao T; Ji QH
Diagn Pathol; 2019 Jun; 14(1):52. PubMed ID: 31159823
[TBL] [Abstract][Full Text] [Related]
20. IL-10 Restores MHC Class I Expression and Interferes With Immunity in Papillary Thyroid Cancer With Hashimoto Thyroiditis.
Lu ZW; Hu JQ; Liu WL; Wen D; Wei WJ; Wang YL; Wang Y; Liao T; Ji QH
Endocrinology; 2020 Oct; 161(10):. PubMed ID: 32348468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
